Health conditions that disproportionately affect women, such as anaemia, endometriosis, polycystic ovary syndrome (PCOS), and gynaecological cancers, often take years to diagnose. The complexity of these conditions and the barriers to timely care severely impact the quality of life for millions of women. Many women report feeling unheard, underserved, unsupported, and dismissed.
We, at EVE, recognised the need for an accessible, discreet, and scientifically-backed solution that empowers women to take control of their health. By creating a device that harnesses the power of period blood, EVE aims to simplify the process of health monitoring, reduce delays in diagnosis, and ultimately improve quality of life for millions of women worldwide. Our mission is to bridge the gap in women’s healthcare, ensuring that women no longer feel unheard or overlooked.
Women deserve more—more research, more innovation, and more options to navigate these challenging health issues. In the UK alone, an estimated 750,000,000 millilitres of period blood is discarded every month. What many don't realise is that, like blood drawn from an arm or finger, menstrual blood is a valuable source of health data.
At EVE, we are committed to improving women's health globally. Be part of the change by learning more about our groundbreaking health solution and how it will empower women to take control of their well-being.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.